New perspectives on anti-HER2/neu therapeutics.
Hongtao Zhang(Chinese Academy of Sciences), Ramachandran Murali(The Wistar Institute), Qiang Wang(Cedars-Sinai Medical Center), M I Greene(University of Pennsylvania)
PubMed
August 1, 2000
Cited by 14
Related Papers
National Survey of Drug-Resistant Tuberculosis in China
|New England Journal of Medicine|2012|649
ErbB receptors: from oncogenes to targeted cancer therapies
|Journal of Clinical Investigation|2007|578
Advances in clinical immunotherapy for gastric cancer
|Biochimica et Biophysica Acta (BBA) - Reviews on Cancer|2021|435
Magnetically Propelled Fish‐Like Nanoswimmers
|Small|2016|271